Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Gross Profit (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Gross Profit data on record, last reported at $11.4 million in Q4 2025.

  • For Q4 2025, Gross Profit rose 62.43% year-over-year to $11.4 million; the TTM value through Dec 2025 reached $38.2 million, up 50.77%, while the annual FY2025 figure was $38.2 million, 50.77% up from the prior year.
  • Gross Profit reached $11.4 million in Q4 2025 per TLSI's latest filing, up from $9.7 million in the prior quarter.
  • Across five years, Gross Profit topped out at $11.4 million in Q4 2025 and bottomed at $2.3 million in Q1 2023.
  • Average Gross Profit over 4 years is $6.4 million, with a median of $6.3 million recorded in 2024.
  • The widest YoY moves for Gross Profit: up 136.26% in 2024, down 37.06% in 2024.
  • A 4-year view of Gross Profit shows it stood at $3.2 million in 2022, then surged by 59.53% to $5.1 million in 2023, then soared by 37.06% to $7.0 million in 2024, then skyrocketed by 62.43% to $11.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $11.4 million in Q4 2025, $9.7 million in Q3 2025, and $9.4 million in Q2 2025.